RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.

Liquefied Natural Gas Limited, together with its subsidiaries, engages in the identification and progression of liquefied natural gas (LNG) development projects to facilitate the production and sale of LNG. It operates through LNG Infrastructure, and Technology and Licensing segments. The company's projects include the Magnolia LNG project located in Lake Charles, Louisiana, the United States; and the Bear Head LNG project situated in Point Tupper, Richmond County, Nova Scotia, Canada. It also designs, develops, owns, and patents OSMR LNG liquefaction process. The company is headquartered in Houston, Texas.

Suda Pharmaceuticals Ltd engages in the development of drug delivery technology in Australia, India, Europe and Korea. It offers ZolpiMist, an oro-mucosal spray formulation of zolpidem tartrate marketed under the brand name of Ambien or Stilnox, a non-benzodiazepine prescribed for the short-term treatment of insomnia. The company's product pipeline includes Sumatriptan, an oral spray formulation for the treatment of acute migraine; and anagrelide, a platelet lowering agent for use in thrombosis, which is used for the treatment of cancer. Suda Pharmaceuticals Ltd has license and supply agreement with Teva Pharmaceuticals International GmbH and Mitsubishi Tanabe Pharma Singapore for ZolpiMist oral spray; product development, licence, and supply agreement with Cann Pharmaceutical Australia Ltd for the development of novel oral spray of pharmaceutical-grade cannabinoid derivatives for the treatment of drug resistant epilepsy, melanoma, and motion sickness; and feasibility and option agreement with Zelira Therapeutics for the use of cannabinoids for a range of uses, including insomnia, autism, opioid reduction, anxiety, pain, and cancer. The company also has a feasibility study and option agreement with Laboratorios Ordesa, S.L. The company was formerly known as Suda Limited and changed its name to Suda Pharmaceuticals Ltd in November 2017. Suda Pharmaceuticals Ltd was incorporated in 1999 and is headquartered in Osborne Park, Australia.

Brederode SA is a venture capital and private equity firm specializing in direct and fund of fund investments. Within direct investment, it specializes in buyouts, middle market, growth capital, leveraged buyout and mature investments. Within fund of fund investments, the firm prefers to invest in private equity funds. It also invests in funds through secondary investments. The firm invests in both unlisted and listed securities. It typically invests in the companies operating in various sectors, including financial, energy, telecommunication and other sectors. It seeks to invest in Europe, United States of America, Asia and Australia. The firm seeks to acquire majority and controlling stakes. It prefers to exit the investment from 4 to 7 years. Brederode SA was founded in 1804 and is based in Luxembourg, Luxembourg.

Rare Element Resources Ltd. explores for mineral properties in the United States. It holds a 100% interest in the Bear Lodge property that comprises the Bear Lodge REE project and the Sundance Gold project located in central Crook County, northeast Wyoming. The company is headquartered in Littleton, Colorado.

Enviro-Serv, Inc. provides property maintenance services in the United States. It offers lawn/landscape maintenance and pest control services. The company was formerly known as Transfer Technology International Corp. and changed its name to Enviro-Serv, Inc. in March 2013 to reflect its new strategic corporate direction. Enviro-Serv, Inc. is based in Tampa, Florida.

Asian Mineral Resources Limited engages in the exploration and development of mineral property interests in Canada. The company primarily explores for copper and vanadium. It holds an option to acquire a 75% interest in the Holt property that covers an area of 3,687 hectares located in east of Duncan, Vancouver Island. The company was incorporated in 2004 and is based in Toronto, Canada. Asian Mineral Resources Limited is a subsidiary of Pala Investments Limited.

PetroFrontier Corp., a junior energy company, explores for and produces petroleum and natural gas in western Canada. It focuses on developing two Mannville heavy oil plays in the Cold Lake and Wabasca areas of Alberta. PetroFrontier Corp. was incorporated in 2009 and is headquartered in Calgary, Canada.

BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company's lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that offers low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers in in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. BioNeutra Global Corporation is based in Edmonton, Canada.

Mint Payments Limited provides mobile payments and transaction services in Australia. The company provides omnichannel payment processing solutions that enable businesses to process and manage their payments. Its products include Mint mPOS solution; Move 5000, a payment processing tool that accepts payments on the shop floor or at the table; Virtual Terminal, a cloud based payment processing tool; Mint Online, an online payment gateway; and Enterprise and White Label solution. It serves the travel, hospitality, and professional services sectors. The company was formerly known as Mint Wireless Limited and changed its name to Mint Payments Limited in December 2014. Mint Payments Limited was incorporated in 2006 and is based in Gladesville, Australia.